Acromegaly diagnosed in a young woman presenting with headache and arthritis

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 10, 2006, Pages 582-587

  Nachtigall, Lisa B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acromegaly; Arthritis; Insulin like growth factor 1; Pituitary adenoma; Trans sphenoidal surgery

Indexed keywords

GROWTH HORMONE; PROLACTIN; SOMATOMEDIN C;

ACROMEGALY; ADULT; ANAMNESIS; ARTHRALGIA; ARTICLE; CANCER SURGERY; CASE REPORT; FEMALE; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TUMOR DIAGNOSIS;

ACROMEGALY; ADENOMA; ADULT; ALGORITHMS; ARTHRITIS, RHEUMATOID; FEMALE; HEADACHE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 33749562087     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0301     Document Type: Article

References (17)

1. Inder WJ et al. (2002) Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management. J Clin Endocrinol Metab 87: 2745-2750
2. Melmed S et al. (1990) Acromegaly. N Engl J Med 322: 966-977
3. Klibanski A and Zervas NT (1991) Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 324: 822-831
4. Bengtsson BA et al. (1988) Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223: 327-335
5. De Marinis LA et al. (2002) Retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. Horm Metab Res 34:137-143
6. Nabarro JD et al. (1987) Acromegaly. Clin Endocrinol 26: 481-512
7. Clemmons DR et al. (2003) Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 88: 4759-4767
8. Giustina A et al. (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85: 526-529
9. Grinspoon S et al. (1995) Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab 80: 927-932
10. Levy A (2004) Pituitary disease: presentation, diagnosis, and management. J Neurol Neurosurg Psychiatry 75: 47-52
11. Renehan AG et al. (2000) The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85: 3417-3424
12. Cohen O et al. (1998) Uterine leiomyomata-a feature of acromegaly. Hum Reprod 13: 1945-1946
13. Melmed S et al. (2002) Current status and future opportunities for controlling acromegaly. Pituitary 5: 185-196
14. Danoff A and Kleinberg D (2003) Somatostatin analogs as primary medical therapy for acromegaly. Endocrine 20: 291-297
15. Sheehan JP et al. (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102: 678-691
16. Klibanski A et al. (1987) Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 66: 806-811
17. Sakharova AA et al. (2005) Clinically silent somatotropinomas may be biochemically active. J Clin Endocrinol Metab 90: 2117-2121